Is topiramate a potential therapeutic agent for cerebral hypoxic/ischemic injury?
Choi
Ji Woong
JW
Division of NanoSciences, Ewha Woman's University, 11-1, Daehyun-dong, Seodaemun-gu, Seoul 120-750, Republic of Korea.
Kim
Won-Ki
WK
D000818:Animals; D001921:Brain / Q000098:blood supply / Q000187:drug effects* / Q000503:physiopathology; D016923:Cell Death / Q000187:drug effects / Q000502:physiology; D002544:Cerebral Infarction / Q000188:drug therapy / Q000503:physiopathology / Q000517:prevention & control; D005632:Fructose / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D020925:Hypoxia-Ischemia, Brain / Q000188:drug therapy* / Q000503:physiopathology; D009410:Nerve Degeneration / Q000188:drug therapy / Q000503:physiopathology / Q000517:prevention & control; D018696:Neuroprotective Agents / Q000494:pharmacology* / Q000627:therapeutic use; D009498:Neurotoxins / Q000037:antagonists & inhibitors / Q000378:metabolism; D017470:Receptors, Glutamate / Q000187:drug effects / Q000378:metabolism; D000077236:Topiramate
D018696:Neuroprotective Agents; D009498:Neurotoxins; D017470:Receptors, Glutamate; D000077236:Topiramate; D005632:Fructose